Next Article in Journal
In Vivo Induction of Apoptosis by Fucoxanthin, a Marine Carotenoid, Associated with Down-Regulating STAT3/EGFR Signaling in Sarcoma 180 (S180) Xenografts-Bearing Mice
Next Article in Special Issue
Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
Previous Article in Journal
The Antiangiogenic Compound Aeroplysinin-1 Induces Apoptosis in Endothelial Cells by Activating the Mitochondrial Pathway
Previous Article in Special Issue
Polyunsaturated Fatty Acids of Marine Macroalgae: Potential for Nutritional and Pharmaceutical Applications
Mar. Drugs 2012, 10(9), 2047-2054; doi:10.3390/md10092047

Clinical Trial: Marine Lipid Suppositories as Laxatives

1,2,* , 2,†, 2,3
, 2,4
, 2,4
, 2
 and 2,4
Received: 3 August 2012 / Revised: 23 August 2012 / Accepted: 5 September 2012 / Published: 20 September 2012
(This article belongs to the Special Issue Marine Lipids)
View Full-Text   |   Download PDF [326 KB, updated 24 February 2015; original version uploaded 24 February 2015]   |   Browse Figure
Abstract: Cod-liver oil and other marine products containing polyunsaturated fatty acids have anti-inflammatory, anti-bacterial and anti-viral effects and may be useful in the treatment of various inflammatory and infectious diseases. We developed suppositories and ointment with 30% free fatty acid (FFA) extract from omega-3 fish oil. Our purpose was to evaluate the safety of marine lipid suppositories and ointment in healthy volunteers and to explore the laxative effect of the suppositories. Thirty healthy volunteers were randomized either to a study group administrating 30% FFA suppositories and applying 30% FFA ointment to the perianal region twice per day for two weeks, or to a control group using placebo suppositories and ointment in a double blinded manner. Results: No serious toxic effects or irritation were observed. In the study group 93% felt the urge to defecate after administration of the suppositories as compared to 37% in the control group (P = 0.001). Subsequently 90% in the study group defecated, compared to 33% in the control group (P = 0.001). Conclusion: The marine lipid suppositories and ointment were well tolerated with no significant toxic side effects observed during the study period. The suppositories have a distinct laxative effect and we aim to explore this effect in further clinical trials.
Keywords: suppositories; ointment; laxative; omega-3 fatty acid; clinical trial suppositories; ointment; laxative; omega-3 fatty acid; clinical trial
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Ormarsson, O.T.; Geirsson, T.; Bjornsson, E.S.; Jonsson, T.; Moller, P.H.; Loftsson, T.; Stefansson, E. Clinical Trial: Marine Lipid Suppositories as Laxatives. Mar. Drugs 2012, 10, 2047-2054.

AMA Style

Ormarsson OT, Geirsson T, Bjornsson ES, Jonsson T, Moller PH, Loftsson T, Stefansson E. Clinical Trial: Marine Lipid Suppositories as Laxatives. Marine Drugs. 2012; 10(9):2047-2054.

Chicago/Turabian Style

Ormarsson, Orri Thor; Geirsson, Thormodur; Bjornsson, Einar Stefan; Jonsson, Tomas; Moller, Pall Hegli; Loftsson, Thorsteinn; Stefansson, Einar. 2012. "Clinical Trial: Marine Lipid Suppositories as Laxatives." Mar. Drugs 10, no. 9: 2047-2054.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert